BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38731867)

  • 1. Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.
    Williams D; Hargrove-Wiley E; Bindeman W; Valent D; Miranda AX; Beckstead J; Fingleton B
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
    Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
    Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
    Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 5. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
    Wu Q; Ba-Alawi W; Deblois G; Cruickshank J; Duan S; Lima-Fernandes E; Haight J; Tonekaboni SAM; Fortier AM; Kuasne H; McKee TD; Mahmoud H; Kushida M; Cameron S; Dogan-Artun N; Chen W; Nie Y; Zhang LX; Vellanki RN; Zhou S; Prinos P; Wouters BG; Dirks PB; Done SJ; Park M; Cescon DW; Haibe-Kains B; Lupien M; Arrowsmith CH
    Nat Commun; 2020 Aug; 11(1):4205. PubMed ID: 32826891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.
    Ramos Solis N; Cannon A; Dilday T; Abt M; Oblak AL; Soloff AC; Kaplan MH; Yeh ES
    Oncoimmunology; 2024; 13(1):2364382. PubMed ID: 38846083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
    Oh S; Kim H; Nam K; Shin I
    BMB Rep; 2017 Mar; 50(3):132-137. PubMed ID: 27931517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer.
    Senapati P; Kato H; Lee M; Leung A; Thai C; Sanchez A; Gallagher EJ; LeRoith D; Seewaldt VL; Ann DK; Schones DE
    Epigenetics Chromatin; 2019 Jul; 12(1):44. PubMed ID: 31315653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.
    Yang W; Li J; Zhang M; Yu H; Zhuang Y; Zhao L; Ren L; Gong J; Bi H; Zeng L; Xue Y; Yang J; Zhao Y; Wang S; Gao S; Fu Z; Li D; Zhang J; Wang T; Shan M; Tang B; Li X
    J Exp Clin Cancer Res; 2022 Feb; 41(1):67. PubMed ID: 35180863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
    Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
    Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.
    Bankaitis KV; Fingleton B
    Clin Exp Metastasis; 2015 Dec; 32(8):847-56. PubMed ID: 26385103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Butyrylation/ Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells after a Long Term Metabolic Reprogramming.
    Mehdikhani F; Ghahremani H; Nabati S; Tahmouri H; Sirati-Sabet M; Salami S
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3597-3601. PubMed ID: 31870099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
    Hamilton N; Austin D; Márquez-Garbán D; Sanchez R; Chau B; Foos K; Wu Y; Vadgama J; Pietras R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
    Banda M; Speyer CL; Semma SN; Osuala KO; Kounalakis N; Torres Torres KE; Barnard NJ; Kim HJ; Sloane BF; Miller FR; Goydos JS; Gorski DH
    PLoS One; 2014; 9(1):e81126. PubMed ID: 24404125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.